COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?

Saved in:

Bibliographic Details
Published in:	Multiple sclerosis Vol. 26; no. 10; p. 1267
Main Author:	Brownlee, Wallace J
Format:	Journal Article
Language:	English
Published:	England 01.09.2020
Subjects:	Betacoronavirus Cladribine Coronavirus Infections COVID-19 Humans Lymphopenia Multiple Sclerosis Pandemics Pneumonia, Viral SARS-CoV-2 COVID-19 multiple sclerosis
ISSN:	1477-0970, 1477-0970
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Commentary-3 content type line 23
ISSN:	1477-0970 1477-0970
DOI:	10.1177/1352458520948211